biotech / news / / India Today
Roche Pharma India has launched a new subcutaneous injection version of its immunotherapy drug Tecentriq.
Roche Pharma India launched a seven-minute subcutaneous Tecentriq injection for lung cancer patients.
KEY POINTS
- The new injection targets non-small cell lung cancer with high PD-L1 expression, benefiting nearly half of NSCLC cases.
- Each dose costs Rs 3.7 lakh, with multiple cycles driving up total treatment expenses significantly.
- Tecentriq is now included in the Central Government Health Scheme and Roche's Blue Tree patient support programme.
COMPANIES
Summarized by Newsio from India Today. How we summarize →